AxoGen

AxoGen is a human tissue company based in Alachua, Florida making products to remedy peripheral nerve damage.[1][2] In 2013 the company raised $18 million in its Initial Public Offering (IPO).[3] AxoGen uses a cell graft technology AVANCE to mimic a human nerve. The company reports recovery in 87 percent of patients with peripheral nerve injuries. AxoGen is part of the Sid Martin Biotechnology Incubator.

See also

References

  1. Graft Helps Nerves Regrow; More Patients Avoid Amputation Through Technique Based on Cadaver Implant December 26, 2012 by Melinda Beck
  2. Nerve repair using grafts from cadavers; SURGERY Grafts from cadavers offer alternative, providing more choice, less traumaby Drew Joseph February 19, 2013 San Francisco Chronicle (SFGate)
  3. [Alachua] Business Briefs November 2013 Florida Trend Magazine

External links


This article is issued from Wikipedia - version of the 12/20/2013. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.